Cargando…

Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling

Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers, and it requires novel treatment approaches and effective drugs. In the present study, we found that treatment with plumbagin, a natural compound, reduced proliferation and survival of the KYSE150 and KYSE450 ESCC cell lines i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Ying-Ya, Yu, Jing, Liu, Ting-Ting, Yang, Kai-Xia, Yang, Li-Yan, Chen, Qun, Shi, Feng, Hao, Jia-Jie, Cai, Yan, Wang, Ming-Rong, Lu, Wei-Hua, Zhang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833725/ https://www.ncbi.nlm.nih.gov/pubmed/29339720 http://dx.doi.org/10.1038/s41419-017-0068-6

Ejemplares similares

Correction to: Suppressive effects of plumbagin on invasion and migration of breast cancer cells via the inhibition of STAT3 signaling and down-regulation of inflammatory cytokine expressions
por: Yan, Wei, et al.
Publicado: (2019)

Sepsis induces muscle atrophy by inhibiting proliferation and promoting apoptosis via PLK1‐AKT signalling
por: Cao, Ying‐Ya, et al.
Publicado: (2021)

Author Correction: Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice
por: Yan, Wei, et al.
Publicado: (2019)

Amelioration of Experimental Autoimmune Encephalomyelitis by Plumbagin through Down-Regulation of JAK-STAT and NF-κB Signaling Pathways
por: Jia, Yan, et al.
Publicado: (2011)

Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA
por: Li, Tingting, et al.
Publicado: (2019)

Effects of Aurora kinase A on mouse decidualization via Stat3-plk1-cdk1 pathway
por: Wang, Peng-Chao, et al.
Publicado: (2021)

Plumbagin inhibits proliferation and promotes apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inactivating PI3K/Akt/mTOR pathway
por: Cai, Zhaowei, et al.
Publicado: (2020)

Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma
por: Xue, Danfeng, et al.
Publicado: (2020)

HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
por: Zeng, Ting-Ting, et al.
Publicado: (2022)

Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma
por: Zheng, Zhen-Yuan, et al.
Publicado: (2022)

Plumbagin attenuates traumatic tracheal stenosis in rats and inhibits lung fibroblast proliferation and differentiation via TGF-β1/Smad and Akt/mTOR pathways
por: Shi, Wei, et al.
Publicado: (2021)

Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1–AKT axis-mediated glycolysis
por: Gao, Wei, et al.
Publicado: (2020)

Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells
por: Zhou, Zhi-Wei, et al.
Publicado: (2015)

Effects of PLK1 on proliferation, invasion and metastasis of gastric cancer cells through epithelial-mesenchymal transition
por: Song, Rui, et al.
Publicado: (2018)

Helicobacter pylori promotes gastric epithelial cell survival through the PLK1/PI3K/Akt pathway
por: Xu, Wenting, et al.
Publicado: (2018)

Plumbagin Prevents Secretory Diarrhea by Inhibiting CaCC and CFTR Channel Activities
por: Yu, Bo, et al.
Publicado: (2019)

Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells
por: Wang, Feng, et al.
Publicado: (2015)

ASC-J9 Blocks Cell Proliferation and Extracellular Matrix Production of Keloid Fibroblasts through Inhibiting STAT3 Signaling
por: Hong, Yi-Kai, et al.
Publicado: (2022)

Plumbagin Enhances the Radiosensitivity of Tongue Squamous Cell Carcinoma Cells via Downregulating ATM
por: Pan, Shu-Ting, et al.
Publicado: (2021)

RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1
por: Yu, Na, et al.
Publicado: (2018)

Antimalarial activity of plumbagin in vitro and in animal models
por: Sumsakul, Wiriyaporn, et al.
Publicado: (2014)

Plumbagin analogs-synthesis, characterization, and antitubercular activity
por: Nayak, Nishi, et al.
Publicado: (2014)

Plumbagin Modulates Leukemia Cell Redox Status
por: Gaascht, François, et al.
Publicado: (2014)

Plumbagin, a Biomolecule with (Anti)Osteoclastic Properties
por: Sultanli, Sevinj, et al.
Publicado: (2021)

The Effects of Plumbagin on Pancreatic Cancer: A Mechanistic Network Pharmacology Approach
por: Pan, Qijin, et al.
Publicado: (2019)

Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances
por: Yin, Zhenhua, et al.
Publicado: (2020)

Aberrant expression of maternal Plk1 and Dctn3 results in the developmental failure of human in-vivo- and in-vitro-matured oocytes
por: Fan, Yong, et al.
Publicado: (2015)

TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways
por: Yang, Run-Wei, et al.
Publicado: (2016)

Modulation of T cell proliferation and cytokine response by Plumbagin, extracted from Plumbago zeylanica in collagen induced arthritis
por: Poosarla, Aparanji, et al.
Publicado: (2011)

Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
por: Zhang, Renjie, et al.
Publicado: (2020)

shRNA targeting PLK1 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells
por: Zhou, Yan, et al.
Publicado: (2020)

Omeprazole Blocks STAT6 Binding to the Eotaxin-3 Promoter in Eosinophilic Esophagitis Cells
por: Zhang, Xi, et al.
Publicado: (2012)

Antioxidant Activities of Plumbagin and Its Cu (II) Complex
por: Tan, Mingxiong, et al.
Publicado: (2011)

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
por: Mehdizadeh, Saber, et al.
Publicado: (2022)

Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1
por: Morris, Edward J., et al.
Publicado: (2017)

EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways
por: Chen, Xiangliu, et al.
Publicado: (2022)

Combination of PI3K/Akt Pathway Inhibition and Plk1 Depletion Can Enhance Chemosensitivity to Gemcitabine in Pancreatic Carcinoma
por: Mao, Yonghuan, et al.
Publicado: (2018)

PLK1 and β-TrCP-Dependent Ubiquitination and Degradation of Rap1GAP Controls Cell Proliferation
por: Wang, Dejie, et al.
Publicado: (2014)

Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways
por: Yang, Run-Wei, et al.
Publicado: (2021)

Synthesis of pH-responsive covalent organic frameworks nanocarrier for plumbagin delivery
por: Wang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8roa06c5tqh41qvt0grrjsaak